Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
Public ClinicalTrials.gov record NCT05629208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Blinded, Placebo-Controlled, Phase 2a, Proof-of-Concept Study to Evaluate Efficacy, Safety, and Tolerability of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)
Study identification
- NCT ID
- NCT05629208
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- Edecesertib Drug
- Edecesertib Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2023
- Primary completion
- Dec 16, 2025
- Completion
- Jan 13, 2026
- Last update posted
- Feb 16, 2026
2023 – 2026
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ARENSIA Exploratory Medicine, LLC | Phoenix | Arizona | 85015 | — |
| Center for Dermatology Clinical Research Inc. | Fremont | California | 94538 | — |
| University of Colorado, Barbara Davis Center, Center for Clinical Research | Aurora | Colorado | 80045 | — |
| Yale Center for Clinical Investigation (YCCI) | New Haven | Connecticut | 06510 | — |
| Clinical Research of West Florida, Inc. | Clearwater | Florida | 33765 | — |
| Reliant Medical Research | Miami | Florida | 33165 | — |
| HMD Research LLC | Orlando | Florida | 32819 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30303 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Dept. of Dermatology, Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM) | Philadelphia | Pennsylvania | 19104 | — |
| Gulf Bank Medical Center | Houston | Texas | 77037 | — |
| Clinical Investigations of Texas | Plano | Texas | 75075 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05629208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05629208 live on ClinicalTrials.gov.